首页>
外国专利>
Drugs for pemphigus containing antibodies against Fas ligand
Drugs for pemphigus containing antibodies against Fas ligand
展开▼
机译:含有抗Fas配体抗体的天疱疮药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention refers to the use of FasL antagonists, e.g. of humanized antibodies directed against human Fas ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigus.
展开▼